文献速递血栓与止血

通过凝血酶原时间与蛇毒凝血酶试剂比较测定因子Ⅱ快速诊断连续病例队列中维生素K缺乏所致凝血病

Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by 1-stage assays with prothrombin time vs Ecarin reagents.
PubMed 文献 · J Thromb Haemost · 2024-08-14

该回顾性连续病例队列纳入2002至2021年292例评估凝血病的患者,比较凝血酶原时间法与蛇毒凝血酶法测定的因子Ⅱ比值及差值对维生素K缺乏的诊断价值,结果显示这些指标具有中等敏感性和中等至良好特异性,且有助于预测维生素K治疗后的临床反应。

要点

  • 在292例连续病例中,25%至38%的患者因子Ⅱ/因子ⅡE检测结果提示维生素K缺乏。
  • 在170例评估维生素K反应的患者中,因子Ⅱ/因子ⅡE比值≤0.84至0.91及因子ⅡE-因子Ⅱ差值>0.04 U/mL对维生素K缺乏的敏感性为47.7%至69.3%,特异性为67.1%至91.5%。
  • 因子Ⅱ/因子ⅡE比值<0.86提示维生素K缺乏,在仅维生素K依赖因子缺乏的患者中更常见(P=0.0001),但在非维生素K依赖因子缺乏者中亦有16%检出。

核心结论

  • 因子Ⅱ/因子ⅡE比较有助于维生素K缺乏的诊断,并可预测凝血病患者对维生素K治疗的临床反应。

研究设计与样本

  • 回顾性连续病例评估,纳入2002年至2021年接受因子Ⅱ/因子ⅡE检测的292例患者(男性58.2%,成人85.6%,中位年龄73岁)。

主要发现

  • 292例患者中84.2%住院,48.3%在重症监护,71.6%有活动性肝病,出院时28%死亡。
  • 25%至38%的患者因子Ⅱ/因子ⅡE结果提示维生素K缺乏。
  • 在170例评估维生素K反应的患者中,因子Ⅱ/因子ⅡE比值≤0.84至0.91和因子ⅡE-因子Ⅱ差值>0.04 U/mL对维生素K缺乏的敏感性为47.7%至69.3%,特异性为67.1%至91.5%。
  • 因子Ⅱ/因子ⅡE比值<0.86提示维生素K缺乏(敏感性47.7%,特异性90.2%),在仅维生素K依赖因子缺乏者中更常见(P=0.0001),但在非维生素K依赖因子缺乏者中16%可检出。
  • 低因子ⅡE常与活动性肝病相关(P=0.0002);根据因子Ⅱ/因子ⅡE比值<0.86判定可能维生素K缺乏者与无可能维生素K缺乏者的死亡率、出血率及凝血酶原复合物和红细胞输注率相似(P≥0.78),但可能维生素K缺乏者接受血浆和纤维蛋白原替代治疗较少(P≤0.024)。

关键数值与推荐

  • 维生素K缺乏定义为维生素K治疗后国际标准化比值纠正/改善≥0.5。
  • 因子Ⅱ/因子ⅡE比值<0.86提示维生素K缺乏,敏感性47.7%,特异性90.2%。
  • 因子Ⅱ/因子ⅡE比值≤0.84至0.91和因子ⅡE-因子Ⅱ差值>0.04 U/mL对维生素K缺乏的敏感性为47.7%至69.3%,特异性为67.1%至91.5%。

临床怎么用

  • 因子Ⅱ/因子ⅡE比较有助于诊断维生素K缺乏并预测凝血病患者对维生素K治疗的临床反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitamin K (VK) deficiency (VKD) impairs γ-carboxylation of VK-dependent factors (VKDFs), resulting in higher factor (F)II levels measured by Ecarin (FIIE) reagents (that convert des-γ-carboxylated FII to meizothrombin) than by prothrombin time (FII) reagents. OBJECTIVES: To evaluate FII/FIIE abnormalities among patients assessed for coagulopathies and identify findings predictive of coagulopathy improvement after VK. METHODS: We retrospectively assessed consecutive cases from 2002 to 2021 with FII/FIIE tests and the sensitivity and specificity of FII/FIIE ratios and FIIE-FII differences for VKD defined as international normalized ratio correction/improvement of ≥0.5 after VK. RESULTS: Two hundred ninety-two patients (males, 58.2%; adults, 85.6%; median age, 73 years) were evaluated (84.2% hospitalized, 48.3% in intensive care, 71.6% with active liver disease, and 28% deceased at discharge) and 25% to 38% had FII/FIIE findings suggestive of VKD. Among 170 patients assessed for response to VK, FII/FIIE ratios of ≤0.84 to 0.91 and FIIE-FII differences of >0.04 U/mL had similar modest sensitivity (47.7%-69.3%) and modest to good specificity (67.1%-91.5%) for VKD. FII/FIIE ratios of <0.86, suggestive of VKD (sensitivity, 47.7%; specificity, 90.2%), were more common in patients deficient in only VKDF (P = .0001), but were detected in 16% with non-VKDF deficiencies. Low FIIE was commonly associated with active liver disease (P = .0002). Patients with and without probable VKD (based on FII/FIIE ratios of <0.86) had similar mortality, bleeding, and rates of prothrombin complex concentrate and red cell transfusions (P ≥ .78), but fewer with probable VKD received plasma and fibrinogen replacement (P ≤ .024). CONCLUSION: FII/FIIE comparison aids the diagnosis of VKD and predicts clinical responses to VK treatment among patients with coagulopathies.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Bourguignon A, Mathews N, Tasneem S, et al. Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by 1-stage assays with prothrombin time vs Ecarin reagents. J Thromb Haemost. 2024. PMID: 39151703. doi:10.1016/j.jtha.2024.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。